Evidence map›Paper›PMID 35699351›Full record

ArticleJournal of surgical oncology2022

Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis.

Aleeza J Leder Macek, Annie Wang, Michael K Turgeon, Rachel M Lee, Maria C Russell, Matthew R Porembka, Rodrigo Alterio, Michelle Ju, Joshua Kronenfeld, Neha Goel and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Aleeza J Leder MacekDepartment of Surgery, Division of Surgical Oncology, NYU Langone Health, New York, New York, USA.ORCID http://orcid.org/0000-0002-3952-822X
Annie WangDepartment of Surgery, Division of Surgical Oncology, NYU Langone Health, New York, New York, USA.
Michael K TurgeonDepartment of Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Rachel M LeeDepartment of Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.ORCID http://orcid.org/0000-0003-2704-839X
Maria C RussellDepartment of Surgery, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.ORCID http://orcid.org/0000-0003-1584-6992
Matthew R PorembkaDepartment of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical School, Dallas, Texas, USA.ORCID http://orcid.org/0000-0003-1596-0058
Rodrigo AlterioDepartment of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical School, Dallas, Texas, USA.ORCID http://orcid.org/0000-0002-2620-7494
Michelle JuDepartment of Surgery, Division of Surgical Oncology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA.ORCID http://orcid.org/0000-0003-0920-7617
Joshua KronenfeldDepartment of Surgery, Division of Surgical Oncology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA.ORCID http://orcid.org/0000-0003-4540-3658
Neha GoelDepartment of Surgery, Division of Surgical Oncology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA.
Jashodeep DattaDepartment of Surgery, Division of Surgical Oncology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida, USA.
Ajay V MakerDepartment of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, Illinois, USA.
Manuel FernandezDepartment of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, Illinois, USA.
Harry RichterDepartment of Surgery, John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois, USA.
Russell S BermanDepartment of Surgery, Division of Surgical Oncology, NYU Langone Health, New York, New York, USA.
Camilo Correa-GallegoDepartment of Surgery, Division of Surgical Oncology, NYU Langone Health, New York, New York, USA.
Ann Y LeeDepartment of Surgery, Division of Surgical Oncology, NYU Langone Health, New York, New York, USA.ORCID http://orcid.org/0000-0002-8143-2635
NYU Langone Health · USUniversity of Miami · USEmory University · USThe University of Texas Southwestern Medical Center · USUniversity of Illinois Chicago · USJohn H. Stroger, Jr. Hospital of Cook County · US

Funding

Research Training Program in Surgical OncologyT32CA211034 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MERCHANT, NIPUN B. · 2016 to 2025
$2.7M
NCI NIH HHS T32 CA211034
6 · The paper itself

Abstract

backgroundDiagnostic laparoscopy (DL) is a key component of staging for locally advanced gastric adenocarcinoma (GA). We hypothesized that utilization of DL varied between safety net (SNH) and affiliated tertiary referral centers (TRCs).

methodsPatients diagnosed with primary GA eligible for DL were identified from the US Safety Net Collaborative database (2012-2014). Clinicopathologic factors were analyzed for association with use of DL and findings on DL. Overall survival (OS) was analyzed by Kaplan-Meier method.

resultsAmong 233 eligible patients, 69 (30%) received DL, of which 24 (35%) were positive for metastatic disease. Forty percent of eligible SNH patients underwent DL compared to 21.5% at TRCs. Lack of insurance was significantly associated with decreased use of DL (OR 0.48, p < 0.01), while African American (OR 6.87, p = 0.02) and Asian race (OR 3.12, p ≤ 0.01), signet ring cells on biopsy (OR 3.14, p < 0.01), and distal tumors (OR 1.62, p < 0.01) were associated with increased use. Median OS of patients with a negative DL was better than those without DL or a positive DL (not reached vs. 32 vs. 12 months, p < 0.005, Figure 1).

conclusionsResults from DL are a strong predictor of OS in GA; however, the procedure is underutilized. Patients from racial minority groups were more likely to undergo DL, which likely accounts for higher DL rates among SNH patients.

Indexed as

AdenocarcinomaLaparoscopyStomach NeoplasmsHospitalsHumansNeoplasm StagingRetrospective Studiesdiagnostic laparoscopydisparitiesgastric adenocarcinomasafety net hospital

Identifiers

PMID35699351
PMCPMC10029827
OpenAlexW4282835666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.